KeyBanc on AptarGroup (ATR): 'Investor Day Highlights Pharma Dominance and Visibility into LT Growth Targets'
Tweet Send to a Friend
KeyBanc analyst Paul Knight reiterated an Overweight rating and $220.00 price target on AptarGroup (NYSE: ATR).The analyst commented: "Investor Day ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
